LXRX Competitors & Alternatives
Compare Lexicon Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
LXRX
Main Stock$2.32
Tradestie Score
59
Market Cap
$512.39M
Revenue Growth
15.7%
Analyst Upside
+62.5%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$6.26
|
$1.12B | - | 52 | Compare |
|
NKTR
Nektar Therapeutics
|
$71.04
|
$1.12B | - | 55 | Compare |
|
PRAX
Praxis Precision Medicines, Inc. Common Stock
|
$318.52
|
$1.12B | - | 58 | Compare |
|
IMTX
Immatics N.V. Ordinary Shares
|
$9.95
|
$1.09B | - | 57 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$13.77
|
$1.05B | 73.5 | 55 | Compare |
|
MDXG
MiMedx Group, Inc
|
$3.95
|
$1.01B | 19.5 | 62 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$8.56
|
$997.16M | - | 50 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.87
|
$996.55M | - | 58 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$86.63
|
$994.20M | - | 56 | Compare |
|
IMNM
Immunome, Inc.
|
$23.61
|
$987.09M | - | 65 | Compare |
More LXRX Analysis
Data updated: Jul 05, 2026 | Industry: Biotechnology (SIC 2834)
234 stocks in this industry